These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 30342064)

  • 1. Neuronal glutamatergic changes and peripheral markers of cytoskeleton dynamics change synchronically 24 h after sub-anaesthetic dose of ketamine in healthy subjects.
    Colic L; McDonnell C; Li M; Woelfer M; Liebe T; Kretzschmar M; Speck O; Schott BH; Bianchi M; Walter M
    Behav Brain Res; 2019 Feb; 359():312-319. PubMed ID: 30342064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Default mode network connectivity change corresponds to ketamine's delayed glutamatergic effects.
    Li M; Woelfer M; Colic L; Safron A; Chang C; Heinze HJ; Speck O; Mayberg HS; Biswal BB; Salvadore G; Fejtova A; Walter M
    Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):207-216. PubMed ID: 30353262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities.
    Li M; Demenescu LR; Colic L; Metzger CD; Heinze HJ; Steiner J; Speck O; Fejtova A; Salvadore G; Walter M
    Neuropsychopharmacology; 2017 May; 42(6):1201-1209. PubMed ID: 27604568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the delayed changes in glutamate levels and functional connectivity with the immediate network effects of S-ketamine.
    Danyeli LV; Sen ZD; Colic L; Kurzweil L; Gensberger-Reigl S; Macharadze T; Götting F; Refisch A; Liebe T; Chand T; Kretzschmar M; Wagner G; Opel N; Jollant F; Speck O; Munk MHJ; Li M; Walter M
    Transl Psychiatry; 2023 Feb; 13(1):60. PubMed ID: 36797238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of ketamine on the pregenual anterior cingulate: linking spontaneous activation, functional connectivity, and glutamate metabolism.
    Gärtner M; Weigand A; Scheidegger M; Lehmann M; Wyss PO; Wunder A; Henning A; Grimm S
    Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):703-714. PubMed ID: 35020021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7T
    Evans JW; Lally N; An L; Li N; Nugent AC; Banerjee D; Snider SL; Shen J; Roiser JP; Zarate CA
    Neuropsychopharmacology; 2018 Aug; 43(9):1908-1914. PubMed ID: 29748628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in the Temporal Neuromolecular and Synaptogenic Effects of the Rapid-acting Antidepressant Drug Ketamine in the Mouse Brain.
    Thelen C; Flaherty E; Saurine J; Sens J; Mohamed S; Pitychoutis PM
    Neuroscience; 2019 Feb; 398():182-192. PubMed ID: 30537521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Antidepressant Effects of Ketamine: the Role of the Pregenual Anterior Cingulate Cortex as a Multimodal Neuroimaging Biomarker.
    Weigand A; Gärtner M; Scheidegger M; Wyss PO; Henning A; Seifritz E; Stippl A; Herrera-Melendez A; Bajbouj M; Aust S; Grimm S
    Int J Neuropsychopharmacol; 2022 Dec; 25(12):1003-1013. PubMed ID: 35948274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept.
    Rodriguez CI; Kegeles LS; Levinson A; Ogden RT; Mao X; Milak MS; Vermes D; Xie S; Hunter L; Flood P; Moore H; Shungu DC; Simpson HB
    Psychiatry Res; 2015 Aug; 233(2):141-7. PubMed ID: 26104826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does ketamine elicit a rapid antidepressant response?
    Kavalali ET; Monteggia LM
    Curr Opin Pharmacol; 2015 Feb; 20():35-9. PubMed ID: 25462290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.
    Krystal JH; Abi-Saab W; Perry E; D'Souza DC; Liu N; Gueorguieva R; McDougall L; Hunsberger T; Belger A; Levine L; Breier A
    Psychopharmacology (Berl); 2005 Apr; 179(1):303-9. PubMed ID: 15309376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine induced changes in regional cerebral blood flow, interregional connectivity patterns, and glutamate metabolism.
    Bryant JE; Frölich M; Tran S; Reid MA; Lahti AC; Kraguljac NV
    J Psychiatr Res; 2019 Oct; 117():108-115. PubMed ID: 31376621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study.
    Taylor MJ; Tiangga ER; Mhuircheartaigh RN; Cowen PJ
    J Psychopharmacol; 2012 May; 26(5):733-7. PubMed ID: 21616979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoskeletal changes in the hippocampus following restraint stress: role of serotonin and microtubules.
    Bianchi M; Heidbreder C; Crespi F
    Synapse; 2003 Sep; 49(3):188-94. PubMed ID: 12774303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression.
    Walter M; Henning A; Grimm S; Schulte RF; Beck J; Dydak U; Schnepf B; Boeker H; Boesiger P; Northoff G
    Arch Gen Psychiatry; 2009 May; 66(5):478-86. PubMed ID: 19414707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial.
    Javitt DC; Carter CS; Krystal JH; Kantrowitz JT; Girgis RR; Kegeles LS; Ragland JD; Maddock RJ; Lesh TA; Tanase C; Corlett PR; Rothman DL; Mason G; Qiu M; Robinson J; Potter WZ; Carlson M; Wall MM; Choo TH; Grinband J; Lieberman JA
    JAMA Psychiatry; 2018 Jan; 75(1):11-19. PubMed ID: 29167877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study.
    Rowland LM; Bustillo JR; Mullins PG; Jung RE; Lenroot R; Landgraf E; Barrow R; Yeo R; Lauriello J; Brooks WM
    Am J Psychiatry; 2005 Feb; 162(2):394-6. PubMed ID: 15677610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of a sub-anaesthetic dose of ketamine on human selective attention.
    Oranje B; van Berckel BN; Kemner C; van Ree JM; Kahn RS; Verbaten MN
    Neuropsychopharmacology; 2000 Mar; 22(3):293-302. PubMed ID: 10693157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in PAS-induced neuroplasticity after a treatment course of intranasal ketamine for depression. Report of three cases from a placebo-controlled trial.
    Gálvez V; Nikolin S; Ho KA; Alonzo A; Somogyi AA; Loo CK
    Compr Psychiatry; 2017 Feb; 73():31-34. PubMed ID: 27886522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anorexia nervosa, zinc deficiency and the glutamate system: The ketamine option.
    Hermens DF; Simcock G; Dutton M; Bouças AP; Can AT; Lilley C; Lagopoulos J
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109921. PubMed ID: 32169564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.